Diabetes Solutions Landscape, US Round 2 Clean Up
Information related to the two Digital health products, Bluedrop device, and the mySugar app has been updated into the attached spreadsheet.
Bluedrop Medical has developed a device that can help to "detect diabetic foot ulcers early when treatment is easier". The company has won the award for "Best AI Application in Healthcare for their innovative ulcer detection device at the recent AIconics Awards held in London".
Inclusion criteria 1 -NO
The Bludrop Medical Device is in pre-marketing stage seeking more funding to get FDA approval as well as expand its market. We did not find any information whether the device is currently available in the market in the UK or in any other country.
inclusion criteria 4 -NO
We did not find any piece of information detailing about the clinical research for Bluedrop Medical device. According to a recent article published in January 2018, "the company is in talks with the NHS about implementing the system, and is examining two sites in the US as a possible pilot once the technology has been approved". The Bluedrop Medical has raised €600,000 ($7,41,834) and planned to manufacture its device in Ireland.
The article states that the Bluedrop device is looking for funding "to support product development and trials through FDA approval".
We have entered NO in column A (line 29) as the Bluedrop does not meet the inclusion criteria 1 & 4. Please see the details in the attached spreadsheet.
mySugar, "a logbook app is easy and complete diabetes tracker". The app helps people with diabetes to log and monitor their daily blood sugar level, record insulin dose, and track carbohydrate count.
According to the website, mySugar is "a smart diabetes companion that’s there for you anytime, anywhere and for free. Face the challenges of diabetes with confidence!"
mySugar Junior, "a logbook app specially developed for children with diabetes and their caregivers". According to mySugar, they have closed its mySugr junior app as "the new operating system requires a much higher quality of graphics than the Junior app is built with, and it is no longer compatible".
As per an article, mySugar is the most popular diabetes app in the world and "has officially passed over one million registered users". It has raised a total of $6,600,000 and the last round of funding was Seed round. mySugar has received $4,800,000 million from Roche Ventures and iSeed Ventures.
It was mentioned in a press release that Roche has acquired the leading mobile diabetes platforms, mySugr.
As requested, we have updated the line 35 for mySugr. Please see the details in the attached spreadsheet.
As per your instructions, we have gone through the entries for line 29 and line 35 for Bluedrop and mySugar Junior. We found that Bludrop does not meet the inclusion criteria 1 & 4. So, we have updated the spreadsheet with the relevant information in line 29.
For mySugar Junior (line 35), we have updated the name of the app as 'mySugar' and all other information related to the app in the attached spreadsheet.